Rath W, Osterhage G, Kuhn W, Gröne H J, Fuchs E
Department of Obstetrics and Gynecology, University of Göttingen, FRG.
Gynecol Obstet Invest. 1993;35(4):209-13. doi: 10.1159/000292702.
Endothelin-1 (ET-1) has potent vasoconstrictor effects and thus may be involved in regulating fetoplacental vascular resistance. By using quantitative in vitro autoradiography, the 125I-ET-1 binding sites in human placentas and umbilical vessels were localized and quantified. A high density of specific 125I-ET-1 binding sites was found in the placental villi and vessels. In the media of umbilical vessels, affinity for the peptide was higher in arteries than in veins. In all structures, 125I-ET-1 binding was inhibited with unlabeled ET-1 in the picomolar range. Unrelated peptides such as oxytocin or atrial natriuretic peptide failed to compete for 125I-ET-1 binding. The localization of binding sites points to a regulation of hemodynamic functions of ET-1 on the fetal side of the placental circulation and supports evidence regarding ET-1 as a paracrine-acting vasoconstrictor.
内皮素-1(ET-1)具有强大的血管收缩作用,因此可能参与调节胎儿-胎盘血管阻力。通过使用定量体外放射自显影技术,对人胎盘和脐血管中的125I-ET-1结合位点进行了定位和定量。在胎盘绒毛和血管中发现了高密度的特异性125I-ET-1结合位点。在脐血管中层,该肽在动脉中的亲和力高于静脉。在所有结构中,皮摩尔范围内的未标记ET-1可抑制125I-ET-1结合。诸如催产素或心房利钠肽等无关肽未能竞争125I-ET-1结合。结合位点的定位表明ET-1对胎盘循环胎儿侧的血流动力学功能具有调节作用,并支持ET-1作为旁分泌作用的血管收缩剂的证据。